

Virpax completed a U.S. Army-backed Probudur study, showing potential for prolonged pain relief and reduced opioid use in surgical recovery.
You can purchase shares of VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. (OTCEM:VRPX) through any online brokerage.
There are no as such competitors for VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc..
There is no analysis for VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. to provide a consensus price target.
The stock price for VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. (OTCEM: VRPX) is $0.0008 last updated October 21, 2026 at 2:43 PM EDT.
There are no upcoming dividends for VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc..
VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc..
VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCEM.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel...